Advertisement
Advertisement

TNGX

TNGX logo

Tango Therapeutics, Inc.

27.07
USD
Sponsored
-1.93
-6.66%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

26.98

-0.09
-0.35%

Tango Therapeutics, Inc. Profile

About

Tango Therapeutics Inc. is a biotechnology company. It focused on discovering and delivering precision cancer medicines. Tango Therapeutics Inc., formerly known as BCTG Acquisition Corp., is based in CAMBRIDGE, Mass.

Info & Links

CEO

Malte Peters

Headquarters

201 BROOKLINE AVE. SUITE 901
BOSTON, MA 02215, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.tangotx.com

Auditor

PricewaterhouseCoopers LLP

Share holders

15

Employees

137

Tango Therapeutics, Inc. Statistics

Valuation Measures

Market Capitalization2

4.39B

Enterprise Value

4.23B

Enterprise Value/EBITDA(ttm)

-35.71

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

63.08

Price to Book(mrq)

10.68

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-297.97%

Return on Equity(ttm)

-41.54%

Return on Invested Capital(ttm)

-41.68%

Return on Assets(ttm)

-33.44%

Income Statement

Revenue(ttm)

56.99M

Revenue Per Share(ttm)

0.39

Gross Profit(ttm)

56.99M

EBITDA(ttm)3

-118.58M

Net Income Available to Common(ttm)

-107.23M

Diluted EPS(ttm)

-0.83

Share Statistics

Beta (5Y Monthly)

1.16

52-Week Change

309.53%

S&P 500 52-Week Change

21.41%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

144.65M

Dividend Yield

0.00%

Float4

135.25M

% Held by Insiders

6.50%

% Held by Institutions

78.99%

Balance Sheet

Total Cash(mrq)

379.84M

Total Cash Per Share(mrq)

2.63

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

27.38%

Quick Ratio(mrq)

27.38%

Book Value Per Share(mrq)

2.72

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.31

Free Cash Flow(ytd)

-44.36M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement